GlaxoSmithKline Pharmaceuticals Limited has notified the stock exchanges regarding the upload of analyst and institutional investor meeting recordings on its official website. The company has communicated this development to both BSE Limited and the National Stock Exchange of India Limited through an official letter dated 6th November 2025.

Regulatory Compliance

The pharmaceutical company has fulfilled its disclosure obligations pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to disclose material events and information that could impact investor decisions.

Recording Availability

The audio recording of the analyst and institutional investor meetings has been uploaded to the company's dedicated investor portal. Stakeholders can access the recording through the company's official website at india-pharma.gsk.com under the investors section.

Corporate Information

The notification was signed by Ajay Nadkarni, who serves as Vice President – Administration, Real Estate & Company Secretary for GlaxoSmithKline Pharmaceuticals Limited. The company is headquartered at GSK House, Dr. Annie Besant Road, Worli, Mumbai, and operates under CIN: L24239MH1924PLC001151.

This disclosure ensures transparency and provides investors with access to important corporate communications and strategic discussions held during the analyst meetings.

GlaxoSmithKline Pharmaceuticals Limited delivered strong financial performance in Q3 FY26, with revenue crossing the ₹1000 crore milestone and reaching ₹102259 lakhs (₹1022.59 crores), representing an 8.1% growth. The pharmaceutical major demonstrated robust profitability with Profit After Tax of ₹27718 lakhs (₹277.18 crores) and significant margin expansion.

Official Financial Results Declaration

The company announced its Q3 FY26 quarterly results for the third quarter ended 31st December 2025 under Regulation 33 of SEBI LODR Regulations. The Board of Directors approved the unaudited standalone and consolidated financial results at their meeting held on 9th February 2026, which commenced at 1:30 PM and concluded at 3:15 PM.

Standalone Financial Performance Highlights

The company's standalone financial metrics showed impressive improvement across key parameters during the third quarter:

The company demonstrated strong operational efficiency with total expenses of ₹67652 lakhs against total income of ₹105441 lakhs, resulting in a healthy profit margin.

Consolidated Financial Performance

On a consolidated basis, the company reported even stronger performance including its subsidiary Biddle Sawyer Limited:

The consolidated results benefited from exceptional items credit of ₹1798 lakhs, which included ₹264 lakhs from profit on sale of surplus residential properties and ₹1798 lakhs from sale of non-operational land site.

Labour Code Impact and Regulatory Changes

The implementation of New Labour Codes resulted in a one-off impact of ₹1182 lakhs during the quarter. The Government of India notified four Labour Codes on November 21, 2025, consolidating 29 existing labour laws. The incremental impact primarily arises due to change in wage definition, with the company continuing to monitor finalisation of Central and State Rules.

Nine Months Performance Overview

For the nine months ended 31st December 2025, the company showed consistent growth trajectory:

Auditor Review and Compliance

The financial results were reviewed by Deloitte Haskins & Sells LLP, with Partner Rajiv Shah signing off on both standalone and consolidated results. The statutory auditors carried out a limited review of the financial results in accordance with Standard on Review Engagements (SRE) 2410, confirming compliance with Indian Accounting Standards and SEBI regulations.